Bordetella Pertussis Flashcards

Bordetella Pertussis: Detailed Overview

Introduction to Bordetella

  • Bordetella is a family of microorganisms that causes disease in both humans and animals.
  • The most important organism in this family is Bordetella pertussis, which causes whooping cough (pertussis).
  • Parapertussis, a cousin of Bordetella pertussis, causes a milder infection compared to pertussis, similar to how parainfluenza relates to influenza.
  • In severe cases, pertussis predominantly affects the bronchioles, posing a significant risk of death to young infants due to necrosis in the bronchioles.
  • In adults, pertussis typically presents as laryngitis or bronchitis, leading to a chronic nagging cough.

Characteristics and Identification

  • On Gram stain, Bordetella appears as a coccobacillus, potentially more coccoid than Haemophilus.
  • It is a slow-growing organism, often outgrown by other respiratory organisms on standard HBA and chocolate agar plates.
  • Selective media is required to culture Bordetella, with growth taking around five days.
  • Due to the slow growth, many labs do not attempt to culture the organism, which is detrimental for studying changes in the organism and potential vaccine escape.
  • Cultures of Bordetella pertussis on Bordet-Gengou medium show raised, pearly-looking colonies described as "bisected pearls."

Epidemiology and Transmission

  • Bordetella pertussis is highly infectious and spreads quickly through communities, especially with poor vaccination coverage.
  • It is purely a human-carried organism.
  • Infectiousness is highest during the catarrhal stage.
  • Secondary attack rates are high, indicating a significant risk of transmission to individuals in close proximity to infected persons.
  • Children under two months of age are at the greatest risk of death from pertussis.

Pathogenesis

  • Bordetella pertussis effectively destroys ciliated cells through various mechanisms.
  • Destruction of cilia impairs mucus clearance, allowing the organism to grow and kill cells.
  • The organism modulates the host immune response, utilizing factors like surfactant A (SPA) and lipo-oligosaccharide (LOS).
  • LOS inhibits complement and is not recognized by surfactant A, which normally controls respiratory infections.
  • The organism can survive within phagocytes, limiting the effectiveness of phagocytosis.
  • Pertussis suppresses lymphocyte-derived immunity and antibody production, leading to poor long-term immunity.
  • In young children, damage extends to the bronchioles, where necrosis leads to plugs of necrotic material that interfere with oxygen exchange, often requiring hospitalization.

Key Virulence Factors

  • Filamentous Hemagglutinin (FHA):
    • Agglutinates erythrocytes when separated.
    • Important for adhesion and initiating invasion.
  • Fimbriae:
    • Small, hair-like appendages on the surface of bacteria.
    • Important for adhesion.
  • Pertactin:
    • Important for cell wall adhesion.
    • Assists in invasion.
  • Adenylate Cyclase Toxin:
    • Interferes with internal cytoplasmic processes, slowing down cellular functions.
    • Impairs leukocyte function.
  • Tracheal Cytotoxin and BTEA:
    • Toxins that damage ciliated epithelial cells.
  • BTEA:
    • Injected through a type three secretion system (think of needles injecting effector proteins).
  • Pertussis Toxin (PT):
    • Not found in parapertussis, potentially explaining milder infections.
    • An AB toxin with a binding (B) part consisting of a pentamer (five parts).

Visual Representation of Pathogenesis

  • The organism attaches to cells via filamentous hemagglutinin and other surface proteins.
  • It injects toxins (like BTEA) using a type three secretion system.
  • Pertussis toxin is excreted, with the binding part (pentamer) facilitating entry and causing cellular damage.
  • Overall process leads to ciliary damage, reactive oxygen species production, cellular death, and cyanotoxicity.

Diagnosis

  • PCR is now the primary method for pertussis identification, according to the CDC.
  • Serological diagnosis was previously emphasized, but pertussis is effective at suppressing antibody production, resulting in poor IgG production.
  • Nasopharyngeal specimens for culture must be collected within the first two weeks of coughing.

Treatment

  • Early treatment is more effective.
  • Adults with chronic coughs are typically not treated.
  • Infants and young children are treated with azithromycin or erythromycin.
  • Penicillin is not effective against Bordetella.
  • Prophylaxis is given to household contacts, especially when infants are at risk.

Vaccination

  • Vaccination is the most important means of preventing pertussis.
  • Falling vaccination rates, often due to anti-vaccination messaging, result in infants being hospitalized.
  • Vaccine protection lasts approximately five years, necessitating revaccination, especially for individuals in households with new babies.
  • The current acellular vaccine is an improvement over previous vaccines, minimizing side effects and encouraging vaccination.
  • Understanding and promoting childhood vaccination schedules is crucial for microbiologists.